Skip to main content
ISRGIntuitive Surgical, Inc.Hold5.9·$407.19+1.33%
ISRG · Concentration risk · 10-K extracted

Intuitive Surgical (ISRG) concentration risks

Updated

The most significant concentration Intuitive Surgical discloses is sole- and single-sourced suppliers, classified HIGH by disclosed size. Below: the full set from the latest 10-K — verbatim quotes, filing references, and a synthesis of what these exposures mean together.

Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results.

Show full disclosure ▾

About TrendMatrix. TrendMatrix is a publisher of general securities research and market commentary. We publish on a regular schedule. All content is the same for every subscriber in a tier — we do not provide personalized investment advice and we do not take into account any individual subscriber's financial situation, investment objectives, risk tolerance, tax situation, or holdings.

Not investment advice. TrendMatrix is not a registered investment adviser. Our content is for informational and educational purposes only. Consult your own licensed investment adviser, broker, or tax professional before making any investment decision.

Conflicts and positions. The TrendMatrix editorial team frequently holds personal long-term positions in securities discussed. We disclose positions held at the time of publication on each piece. We maintain a trading-window policy: we do not initiate or close positions in the same direction as a TrendMatrix publication within 24 hours before or 72 hours after publication.

No paid promotion. TrendMatrix does not accept payment from any issuer, broker, or third party in exchange for coverage of any security. Our sole compensation is subscription revenue.

No fiduciary duty. No fiduciary, advisory, or agency relationship is created between you and TrendMatrix by reading our content or subscribing to our service.

Performance. Past performance is not indicative of future results. Performance figures reflect the published model only and do not reflect any individual subscriber's actual results.

Methodology · Editorial policy & full disclaimer

Source: Intuitive Surgical’s SEC Form 10-K filed view the filing on SEC EDGAR ↗

At a glance

Disclosed-size breakdown · 3 disclosed concentrations

HIGH1
MEDIUM2
LOW0
Disclosed concentrations

Each card carries a disclosed-size chip (HIGH / MEDIUM / LOW — how large the exposure is as a share of revenue, not how dangerous it is) and a nature tag: Built-in(the company’s own model, geography, or products) or Outside party (an external customer, supplier, or distributor it relies on).

HIGHOutside partySupplier

sole- and single-sourced suppliers

10-K Item 1A: 'Some of the components necessary for the assembly of our products are currently provided to us by sole-sourced suppliers or single-sourced suppliers'
SEC 10-K · filed Feb 2026
MEDIUMBuilt-inGeographic
32%

OUS markets

10-K Item 1A: 'Revenue from OUS markets accounted for approximately 32%, 33%, and 34% of our revenue for the years ended December 31, 2025, 2024, and 2023, respectively'
SEC 10-K · filed Feb 2026
MEDIUMBuilt-inGeographic

Mexico manufacturing

10-K Item 1A: 'potential tariffs on goods imported from Mexico where we manufacture a significant majority of our instruments and accessories that we sell'
SEC 10-K · filed Feb 2026
TrendMatrix Research · concentration synthesis

What these concentrations mean together

updated 2026-06-24

The company's disclosed concentration profile spans three exposures: a high-share supplier dependency, a moderate geographic revenue tilt, and a moderate manufacturing location exposure. Some of the components for the company's products are currently provided by sole-sourced or single-sourced suppliers, a high-share dependency. For a company whose systems are used in surgical procedures where component failure carries significant patient-safety implications, sole-source dependencies introduce a supply chain vulnerability that is difficult to substitute quickly if a vendor fails to deliver. This dependency is not structural in the sense of being a market feature but reflects current sourcing decisions that the company has flagged as a risk. Revenue from outside U.S. markets accounted for approximately 32% of total revenue for the year ended December 31, 2025, a moderate geographic concentration that is structural — it reflects the global adoption trajectory for robotic surgical systems and is a natural feature of a product sold across major hospital markets worldwide. A significant majority of the company's instruments and accessories are manufactured in Mexico, a moderate structural exposure that carries tariff sensitivity; the filing specifically highlights the potential effect of tariffs on goods imported from Mexico. Together, the profile is defined by a manufacturing supply dependency at the top of the risk hierarchy, a moderate international revenue exposure, and a cross-border manufacturing concentration that adds policy-driven cost risk. The single-source supplier relationships and the Mexico tariff exposure are the most actionable near-term variables to monitor.

For the engine’s reasoning on ISRG’s current verdict — including which dimensions drove the score — see the per-dimension breakdown.

Industry peers · Medical Instruments & Supplies

Peer concentration profile

SymbolNameHIGHMEDIUMLOWTotal
BAXBaxter International Inc.1203
ISRGIntuitive Surgical, Inc.1203
ATRAptarGroup, Inc.1102
BDXBecton, Dickinson and Company1102
ALGNAlign Technology, Inc.1001
AVTRAvantor, Inc.1001

Concentration counts reflect items disclosed in each peer’s most recent 10-K; disclosed-size classification uses TrendMatrix’s internal 10-K extraction taxonomy.

Concentration disclosures are extracted verbatim from SEC 10-K filings; the disclosed-size classification and the synthesis above are engine-derived. Size reflects how large each exposure is against fixed share thresholds (HIGH >50%, MEDIUM 25–50%, LOW <25% or an explicit diversification statement), not a judgment of how dangerous it is, and is not a buy/sell rating, a price target, or a view on the stock. Not a complete list of risk factors — see the full filing.

Home Stocks ISRG Concentration risk